Financial Gravity Asset Management’s Invesco BulletShares 2023 High Yield Corporate Bond ETF BSJN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$25K Buy
+262
New +$6.65K 0.01% 760
2019
Q4
Sell
-5,786
Closed -$151K 1749
2019
Q3
$151K Sell
5,786
-2,927
-34% -$76.2K 0.13% 147
2019
Q2
$227K Sell
8,713
-1,404
-14% -$36.6K 0.19% 125
2019
Q1
$264K Buy
+10,117
New +$260K 0.21% 100

Other funds holding BSJN

Financial Gravity Asset Management's BSJN Position: Q3 2021 in Review

Financial Gravity Asset Management opened a new position in Invesco BulletShares 2023 High Yield Corporate Bond ETF (BSJN) in Q3 2021: 262 shares worth $25K. The stake represents 0.01% of the portfolio and ranks #760 among its holdings. This is a return to the name: Financial Gravity Asset Management previously reported a position in BSJN as recently as Q3 2019.

Financial Gravity Asset Management first reported a position in BSJN in Q1 2019 and has held it in 4 quarters since. The position peaked at $264K in Q1 2019. 119 funds tracked by Wall St. Rank hold BSJN as of Q3 2021.

  • Financial Gravity Asset Management held 262 shares of Invesco BulletShares 2023 High Yield Corporate Bond ETF worth $25K as of Q3 2021.
  • Invesco BulletShares 2023 High Yield Corporate Bond ETF was a new Financial Gravity Asset Management position in Q3 2021.
  • Invesco BulletShares 2023 High Yield Corporate Bond ETF made up 0.01% of Financial Gravity Asset Management's portfolio in Q3 2021, its #760 holding.
  • Financial Gravity Asset Management first reported a position in Invesco BulletShares 2023 High Yield Corporate Bond ETF in Q1 2019 and has held it in 4 quarters since.
  • Financial Gravity Asset Management's Invesco BulletShares 2023 High Yield Corporate Bond ETF position peaked at $264K in Q1 2019.
  • 119 funds tracked by Wall St. Rank held Invesco BulletShares 2023 High Yield Corporate Bond ETF as of Q3 2021.

Based on Financial Gravity Asset Management's 13F filing for Q3 2021, filed 12 Nov 2021.